Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference45 articles.
1. KöhneCH, PetersGJ (2000) UFT: mechanism of drug action. Oncol Williston Park N14:13–18
2. OmuraK (2003) Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines. Int J Clin Oncol8:132–138.
https://doi.org/10.1007/s10147-003-0330-z
3. Boisdron-CelleM, Guérin-MeyerV, CapitainO (2013) 5-fluorouracile: MSI, pharmacocinétique, DPD, TYMS et MTHFR. In: Médecine personnalisée en cancérologie digestive. Springer, Paris, pp 75–92
4. AlcindorT, BeaugerN (2011) Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol18:18–25
5. GrahamMA, LockwoodGF, GreensladeD et al (2000) Clinical pharmacokinetics of oxaliplatin: a critical review. Clin Cancer Res6:1205–1218
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献